← Back to Vaccine Database

P16_37-63

Peptide based vaccine · VDDBV0562

Target & Classification

HPVHuman papillomavirus
Peptide based vaccine
Recurrent Respiratory Papillomatosis; Human Papillomavirus Type 16
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT01462838 Phase 2Recurrent Respiratory Papillomatosis
NCT02526316 Phase 1Human Papillomavirus Type 16